Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
elisabetta.ferretti@uniroma1.it
Elisabetta Ferretti
Professore Ordinario
Struttura:
DIPARTIMENTO DI MEDICINA SPERIMENTALE
E-mail:
elisabetta.ferretti@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients
CURRENT ONCOLOGY REPORTS
2024
Immunotherapy in melanoma: Can we predict response to treatment with circulating biomarkers?
PHARMACOLOGY & THERAPEUTICS
2024
Evaluating cell culture reliability in pediatric brain tumor primary cells through DNA methylation profiling
NPJ PRECISION ONCOLOGY
2024
Bisphenol-A in Drinking Water Accelerates Mammary Cancerogenesis and Favors an Immunosuppressive Tumor Microenvironment in BALB–neuT Mice
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2024
Open-ST: High-resolution spatial transcriptomics in 3D
CELL
2024
New Advances in Metabolic Syndrome, from Prevention to Treatment: The Role of Diet and Food
NUTRIENTS
2023
Role of SIRT3 in Microgravity Response: A New Player in Muscle Tissue Recovery
CELLS
2023
Hedgehog-GLI and Notch Pathways Sustain Chemoresistance and Invasiveness in Colorectal Cancer and Their Inhibition Restores Chemotherapy Efficacy
CANCERS
2023
A diagnostic circulating miRNA signature as orchestrator of cell invasion via TKS4/TKS5/EFHD2 modulation in human gliomas
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
2023
Antitumoral effects of Bortezomib in malignant mesothelioma: evidence of mild endoplasmic reticulum stress in vitro and activation of T cell response in vivo
BIOLOGY DIRECT
2023
Prospective validation study of a novel integrated pathway based on clinical features, MRI biomarkers and microRNAs for early detection of prostate cancer
EUROPEAN UROLOGY ONCOLOGY
2023
Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
2023
Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistance
BIOMÉDECINE & PHARMACOTHÉRAPIE
2023
Sarcopenic obesity research perspectives outlined by the sarcopenic obesity global leadership initiative (SOGLI) - Proceedings from the SOGLI consortium meeting in rome November 2022
CLINICAL NUTRITION
2023
Platelet-derived circRNAs signature in patients with gastroenteropancreatic neuroendocrine tumors
JOURNAL OF TRANSLATIONAL MEDICINE
2023
β-arrestin1-E2F1-ac axis regulates physiological apoptosis and cell cycle exit in cellular models of early postnatal cerebellum
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
2023
Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs
JOURNAL OF TRANSLATIONAL MEDICINE
2023
Network analysis identifies circulating miR-155 as predictive biomarker of type 2 diabetes mellitus development in obese patients: a pilot study
SCIENTIFIC REPORTS
2023
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value
BIOMARKER RESEARCH
2023
mTORC1/ERK1/2 Interplay Regulates Protein Synthesis and Survival in Acute Myeloid Leukemia Cell Lines
BIOLOGY
2023
1
2
3
4
5
6
seguente ›
ultima »
Progetti di Ricerca
Defining the biological role of endocrine disruptors (ED) in breast cancer development and progression
Protein Kinase Inhibitor treatment in Advanced Thyroid Cancer: evaluation of liquid biopsy as a tool for prediction of response to therapy
Gruppi di ricerca
Integrated Diagnostics in Prostate Cancer supported by Computational Algorithms (AI and network analysis)
Gestational diabetes; Risk Factors; Outcomes
Laboratori di ricerca
Functional omics data and Precision Medicine
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma